Cost-Effectiveness of Diabetes Education

Journal of the American Dietetic Association

Volumn 108, Issue 4 SUPPL., 2008, Pages S6-

  Urbanski, Patti ^a   Wolf, Anne ^a   Herman, William H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 40749085648     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2008.01.019     Document Type: Article

References (27)

1. American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 26 (2003) 917-932
2. Herman W.H., Urbanski P., and Wolf A.M. Cost effectiveness issues of diabetes prevention and treatment. Newsflash 29 1 (2008). http://www.dce.org/links/spring_Newsflash_cost.htm In press. Reprint of article available at: http://www.dce.org/links/spring_Newsflash_cost.htm
3. Herman W.H., Brandle M., Zhang P., Williamson D.F., Matulik M.J., Ratner R.E., Lachin J.M., and Engelgau M.M. The Diabetes Prevention Program Research Group: Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care 26 (2003) 36-47
4. Palmer A.J., Roze S., Valentine W.J., Spinas G.A., Shaw J.E., and Zimmet P.Z. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. Clin Ther 26 (2004) 304-321
5. Caro J.J., Getsios D., Caro I., Klittich W.S., and O'Brien J.A. Economic evaluation of therapeutic interventions to prevent type 2 diabetes in Canada. Diabet Med 21 (2004) 1229-1236
6. Eddy D.M., Schlessinger L., and Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med 143 (2005) 251-264
7. Eastman R.C., Javitt J.C., Herman W.H., Dasbach E.J., Copley-Merriman C., Maier W., Dong F., Manninen D., Zbrozek A.S., Kotsanos J., Garfield S.A., and Harris M. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care 20 (1997) 735-744
8. The CDC Diabetes Cost-Effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 287 (2002) 2542-2551
9. Coyle D., Palmer A.J., and Tam R. Economic evaluation of pioglitazone hydrochloride in the management of type 2 diabetes mellitus in Canada. Pharmacol Econ 20 suppl 1 (2002) 31-42
10. Clarke P.M., Gray A.M., Briggs A., Stevens R.J., Matthews D.R., Holman R.R., and UKPDS 72 United Kingdom Prospective Diabetes Study. Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Diabetologia 48 (2005) 868-877
11. Funnell M.M., Brown T.L., Childs B.P., Haas L.B., Hosey G.M., Jensen B., Maryniuk M., Peyrot M., Piette J.D., Reader D., Siminerio L.M., Weinger K., and Weiss M.A. National standards for diabetes self-management education. Diabetes Care 30 (2007) 1630-1637
12. Gage H., Hampson S., Skinner T.C., Hart J., Storey L., Foxcroft D., Kimber A., Cradock S., and McEvilly E.A. Educational and psychosocial programmes for adolescents with diabetes: approaches, outcomes and cost-effectiveness. Patient Educ Couns 53 (2004) 333-346
13. Hampson S.E., Skinner T.C., Hart J., Storey L., Gage H., Foxcroft D., Kimber A., Shaw K., and Walker J. Effects of educational and psychological interventions for adolescents with diabetes mellitus: A systematic review. Health Technol Assess 5 (2001) 1-79
14. Klonoff D.C., and Schwartz D.M. An economic analysis of interventions for diabetes. Diabetes Care 23 (2000) 390-404
15. Loveman E., Cave C., Green C., Royle R., Dunn N., and Waugh N. The clinical and cost-effectiveness of patient education models for diabetes: A systematic review and economic evaluation. Health Technol Assess 7 (2003) 1-190
16. Norris S.L., Nichols P.J., Caspersen C.J., Glasgow R.E., Engelgau M.M., Jack Jr. L., Snyder S.R., Carande-Kulis V.G., Isham G., Garfield S., Briss P., McCulloch D., and Task Force on Community Preventive Services. Increasing diabetes self-management education in community settings: A systematic review. Am J Prev Med 22 (2002) 39-66
17. Cranor C.W., Bunting B.A., and Christensen D.B. The Asheville project: Long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 43 (2003) 173-184
18. Diijkstra R.F., Niessen L.W., Braspenning J.C., Adang E., and Grol R.T. Patient-centered and professional-directed implementation strategies for diabetes guidelines: A cluster-randomized trial-based cost-effectiveness analysis. Diabet Med 23 (2005) 164-170
19. Gilmer T.P., Roze S., Valentine W.J., Emy-Albrecht K., Ray J.A., Cobden D., Nicklasson L., Philis-Tsimikas A., and Palmer A.J. Cost-effectiveness of diabetes case management for low-income populations. Health Serv Res 42 (2007) 1943-1959
20. Keers J.C., Groen H., Sluiter W.J., Bouma J., and Links T.P. Cost and benefits of a multidisciplinary intensive diabetes education programme. J Eval Clin Pract 11 (2005) 293-303
21. Ragucci K.R., Fermo J.D., Wessell A.M., and Chumney E.C. Effectiveness of pharmacist-administered diabetes mellitus education and management services. Pharmacotherapy 25 (2005) 1809-1816
22. Trento M., Passera P., Borgo E., Tomalino M., Bajardi M., Brescianini A., Tomelini M., Giuliano S., Cavallo F., Miselli V., Bondonio P., and Porta M. A 3-year prospective randomized controlled clinical trial of group care in type 1 diabetes. Nutr Metab Cardiovasc Dis 15 (2005) 293-301
23. Pastors J.G., Franz M.J., Warshaw H., Daly A., and Arnold M.S. How effective is medical nutrition therapy in diabetes care?. J Am Diet Assoc 103 (2003) 827-831
24. American Dietetic Association. Evidence based library. ADA Evidence Library Web site. http://www.adaevidencelibrary.com Accessed December 15, 2007
25. Franz M.J., Splett P.L., Monk A., Barry B., McClain K., Weaver T., Upham P., Bergenstal R., and Mazze R.S. Cost effectiveness of medical nutrition therapy provided by dietitians for persons with non-insulin-dependent diabetes mellitus. J Am Diet Assoc 96 (1995) 1018-1024
26. Wolf A.M., Conaway M.R., Crowther J.Q., Hazen K.Y., Nadler J.L., Oneida B., and Bovbjerg V.E. Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN). Diabetes Care 27 (2004) 1570-1576
27. Wolf A.M., Siadaty M., Yaeger B., Crowther J.Q., Conaway M., Nadler J., and Bovberg V.E. Effects of lifestyle intervention on health care costs: Improving Control with Activity and Nutrition (ICAN). J Am Diet Assoc 107 (2007) 1365-1373